Risk of Ovarian Hyperstimulation Syndrome in Infertile Patients With PCOS Treated by HP HMG

    December 2022 in “ Archives of Clinical Trials
    M Mohammed, Hamza Elmahaishi, Norhazirah Abdul Halim, M. S. Elmahaishi
    Image of study
    TLDR Treating PCOS patients with HP HMG significantly raises the risk of ovarian hyperstimulation syndrome, needing careful dose management.
    The study "Risk of ovarian hyperstimulation syndrome in infertile patients with PCOS treated by HP HMG" by Manar Tareq Mohammed, Hamza Elmahaishi, Narges R Ben Halim, and Elmahaishi MS, investigates the risk of ovarian hyperstimulation syndrome (OHSS) in infertile patients with Polycystic Ovary Syndrome (PCOS) who are treated with Highly Purified Human Menopausal Gonadotropin (HP HMG). The study found that the risk of OHSS in these patients is significant, suggesting that careful monitoring and dosage adjustments are necessary when treating PCOS patients with HP HMG to prevent this potentially serious complication. The study, however, does not mention the number of participants involved, which is a crucial factor in determining the strength of the study.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 11 results

      community 11-month update. This time wet hair comparison!

      in Progress Pictures  108 upvotes 1 year ago
      The post discusses an 11-month hair loss treatment journey using dutasteride, minoxidil, nizoral, and 1.5mm derma rolling. The responses inquire about the frequency of derma rolling and express optimism for further progress.

      community Low-Dose Oral Minoxidil Does Not Significantly Affect BP

      in Minoxidil  178 upvotes 1 month ago
      Low-dose oral minoxidil is used for hair loss and does not significantly affect blood pressure but may increase heart rate and cause hypotensive symptoms. Some users experience side effects like palpitations and shortness of breath, while others find it effective; topical minoxidil with tretinoin is also considered.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  55 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

    Similar Research

    5 / 1000+ results
      An Update of Polycystic Ovary Syndrome: Causes and Therapeutic Options

      research An Update of Polycystic Ovary Syndrome: Causes and Therapeutic Options

      5 citations, October 2022 in “Heliyon”
      Polycystic ovary syndrome, a disorder causing menstrual issues and infertility, can be treated with lifestyle changes, medication, herbal remedies, surgery, and assisted reproductive techniques like artificial insemination and IVF.